ALSO NOTED: Merck exec testifies; Atrium buys health outfit; GSK gets OK for acquisition; and much more...

Email LinkedIn
Tools

> A Merck executive testified that she was not trying to dissuade a researcher, Dr. Eric Topol, from publishing data raising serious safety concerns about Vioxx. Report

> Atrium Biotechnologies will pay C$107 million for a Pittsburgh firm that makes health and nutritional products. Report

> A Canadian court has approved GlaxoSmithKline's takeover of ID Biomedical. Report

> Isotechnika has released nine-month data for its Phase III psoriasis trial. Release

> Eisai has filed a patent suit against Teva over its generic version of Aricept. Release

> MedImmune has licensed new antibody-enhancing technologies. Release

> New studies point to effectiveness of novel drugs in fighting gout and colitis. Report

> Roche has inked a licensing deal to use Ambrx technology to develop new proteins and peptides. Report

> Pharmacyclics is touting preclinical results for its lead anti-cancer product. Release

And Finally… A 10-year-old Chinese girl has tested positive for the H5N1 virus. Article